• Syringin Targets EGFR/PI3K/Akt in RCC

  2026-08-11

  The reference study identifies Syringin as a natural product that suppresses renal cell carcinoma cell growth and increases sensitivity to sunitinib through EGFR/PI3K/Akt pathway modulation. Its integrated computational and cell-based design provides a mechanistic rationale for investigating Syringin in sunitinib-resistant RCC, while leaving in vivo and clinical validation for future work.

• Dextrose: Designing Better Hypoxia Assays

  2026-08-11

  Dextrose (D-glucose) is more than a routine carbon source in glucose metabolism research. This article presents a rigorous framework for using substrate availability to interpret hypoxia, nutrient competition, and immune-metabolic phenotypes in tumor models.

• PS Nanoplastics, Cadmium, and Intestinal Apoptosis

  2026-08-10

  The reference study identifies the IP3R/Ca2+/STAT3 axis as a mechanistic link between polystyrene nanoplastic–cadmium co-exposure and intestinal-cell apoptosis. By combining C. elegans and Caco-2 models with pharmacological inhibition and calcium chelation, it provides evidence that dysregulated intracellular calcium is a functional component of the toxic response rather than only a correlated signal.

• DiR for Long-Term Cell Membrane Imaging

  2026-08-09

  DiR (DiIC 18 (7)) combines durable membrane retention with near-infrared detection for live-cell tracking, neuronal tracing, extracellular-vesicle studies, and tissue imaging. This workflow-focused guide explains how to label, image, and troubleshoot membrane-associated fluorescence while using DiR as a complementary readout in advanced nanomedicine experiments.

• Sulfachloropyridazine in E. tenella Cecal Omics

  2026-08-08

  The reference study combines 16S rRNA sequencing with LC-MS/MS metabolomics to examine how ethanamizuril, sulfachlorpyridazine, and their combination reshape the cecal ecosystem of chickens infected with Eimeria tenella. Its main contribution is to connect anticoccidial treatment with microbiota and metabolite responses, while showing that low-dose combination treatment produced limited additional disruption at the measured time point.

• Cy3 NHS ester (non-sulfonated): Practical Guide

  2026-08-07

  Cy3 NHS ester (non-sulfonated) provides an orange fluorescent NHS ester for labeling accessible amino groups on soluble proteins, peptides, and amino-modified oligonucleotides. Its water insolubility requires DMSO or DMF-based handling, so it is not the preferred choice for strictly aqueous workflows or co-solvent-sensitive biomolecules.

• Targeting AR Dimer Interface: Novel Antagonists Against CRPC

  2026-08-07

  The referenced study introduces a new class of androgen receptor (AR) antagonists that disrupt the AR dimer interface rather than the traditional ligand-binding pocket, demonstrating efficacy even against drug-resistant AR mutants in prostate cancer. This breakthrough expands therapeutic options for castration-resistant prostate cancer (CRPC) and offers a blueprint for the rational design of next-generation antiresistance agents.

• Safe DNA Gel Stain: Workflow Advances in RNA and DNA Visuali

  2026-08-06

  Safe DNA Gel Stain by APExBIO delivers a safer, blue-light compatible solution for visualizing nucleic acids, reducing DNA damage and mutagenic risk in molecular workflows. Its versatility and sensitivity support advanced protocols, from viral RNA research to cloning, making it an essential upgrade for nucleic acid detection.

• Syringin Natural Product: Translational Innovation Beyond RC

  2026-08-06

  Explore the unique translational value of the Syringin natural product in bioactive compound research. This article offers advanced mechanistic analysis, protocol nuances, and practical guidance distinct from existing RCC workflow articles.

• Pexidartinib (PLX3397): Unlocking Macrophage Modulation in T

  2026-08-05

  This thought-leadership article explores the strategic deployment of Pexidartinib (PLX3397) for translational oncology, emphasizing mechanistic insights into CSF1R-mediated macrophage modulation, the evolving landscape of tumor microenvironment research, and actionable protocol guidance for researchers. By synthesizing recent breakthroughs in TAM-targeted therapy—including SPP1 inhibition—and highlighting APExBIO’s product advantages, this article equips scientists to advance anti-tumor strategies beyond conventional approaches.

• Synergistic Photothermal and Immunotherapy via GSH-Responsiv

  2026-08-05

  This study introduces a novel GSH-responsive metal-organic framework (MOF) nanoparticle system co-loaded with indocyanine green (ICG) and a PD-1 inhibitory polypeptide, enabling targeted photothermal therapy (PTT) combined with immunotherapy against melanoma. The approach demonstrates enhanced tumor ablation and immune activation, providing a significant advancement for nanoplatform-enabled cancer treatment.

• Puromycin Aminonucleoside (SKU A3740): Lab-Proven Podocyte I

  2026-08-04

  This article explores practical challenges in nephrotic syndrome research and demonstrates how Puromycin aminonucleoside (SKU A3740) from APExBIO delivers robust, reproducible results in podocyte injury, FSGS, and cytotoxicity workflows. Scenario-driven Q&A blocks provide actionable guidance for experimental design, protocol optimization, and product selection, helping biomedical researchers leverage validated solubility, IC50, and workflow integration for consistent data.

• Efficient Purification of Recombinant Annexin V for Biophysi

  2026-08-04

  Burger et al. present a rapid and highly effective protocol for purifying recombinant human Annexin V, optimizing its suitability for ion channel and structural studies. Their method, which leverages calcium-dependent phospholipid binding and mild cell disruption, addresses key challenges in obtaining pure Annexin V for advanced biophysical and cell death research applications.

• Cy3 NHS Ester (Non-Sulfonated): Technical Guide and Protocol

  2026-08-03

  Cy3 NHS ester (non-sulfonated) enables covalent, fluorescent labeling of primary amines on proteins, peptides, and oligonucleotides for sensitive detection in imaging and biochemical assays. It is appropriate for workflows that support organic co-solvents but should not be used for labeling in strictly aqueous buffers or for long-term solution storage.

• D-Lin-MC3-DMA: Redefining RNA Delivery for Translational Imp

  2026-08-03

  Explore how D-Lin-MC3-DMA, an advanced ionizable cationic liposome, is driving a paradigm shift in siRNA and mRNA therapeutics. This article bridges mechanistic insight, machine learning–guided formulation, and translational strategy to empower researchers in gene silencing, immunomodulation, and beyond—advancing well beyond standard product discussions.

16346 records 1/1090 page Next 12345 下5页 Last page